- Email: [email protected]
Award pages
The Platinum Hall of Fame European Urology would like to recognize the award-winning authors and exceptional reviewers who ensure that ‘your’ platinum journal remains a cut above the rest. Best Scientific Paper Prizes 2000 to the Present
2006
2000
Prevalence of Asymptomatic Coronary Artery Disease in Men with Vasculogenic Erectile Dysfunction: A Prospective Angiographic Study
Laparoscopic Radical Prostatectomy: Technical and Early Oncological Assessment of 40 Operations B. Guillonneau, X. Cathelineau, E. Barret, F. Rozet, G. Vallancien European Urology 1999;36:14–20
2001 RPLND or Primary Chemotherapy in Clinical Stage IIA/B Nonseminomatous Germ Cell Tumors? Results of a Prospective Multicenter Trial Including Quality of Life Assessment
C. Vlachopoulos, K. Rokkas, N. Ioakeimidis, C. Aggeli, A. Michaelides, G. Roussakis, C. Fassoulakis, A. Askitis, C. Stefanadis European Urology 2005;48:996–1002
2007 Excellent Long-Term Cancer Control with Elective Nephron-Sparing Surgery for Selected Renal Cell Carcinomas Measuring More Than 4 cm F. Becker, S. Siemer, M. Hack, U. Humke, M. Ziegler, M. Stöckle European Urology 2006;49:1058–1064
L. Weissbach, R. Bussar-Maatz, H. Flechtner, U. Pichlmeier, M. Hartmann, L. Keller European Urology 2000;37:582–594
& Elective Nephron-Sparing Surgery Should Become Standard Treatment for Small Unilateral Renal Cell Carcinoma: Long-term Survival Data of 216 Patients
2002
F. Becker, S. Siemer, U. Humke, M. Hack, M. Ziegler, M. Stöckle European Urology 2006;49:308–313
Nonrandomized Comparison of Open Flank versus Laparoscopic Nephrectomy in 249 Patients with Benign Renal Disease P. Fornara, C. Doehn, H.-J. Friedrich, D. Jocham European Urology 2001;40:24–31
2003 Laparoscopic Dismembered Pyeloplasty – The Method of Choice in the Presence of an Enlarged Renal Pelvis and Crossing Vessels I.A. Türk, J.W. Davis, B. Winkelmann, S. Deger, F. Richter, M.D. Fabrizio, B. Schönberger, G.H. Jordan, S.A. Loening European Urology 2002;42:268–275
2004 The Side Effects of Bacillus Calmette-Guérin in the Treatment of Ta T1 Bladder Cancer do not Predict its Efficacy: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial R.J. Sylvester, A.P.M. Van Der Meijden, W. Oosterlinck, W. Hoeltl, A.V. Bono European Urology 2003;44:423–428
& Maintenance Bacillus Calmette-Guérin for Ta T1 Bladder Tumors is not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial A.P.M. Van Der Meijden, R.J. Sylvester, W. Oosterlinck, W. Hoeltl, A.V. Bono European Urology 2003;44:429–434
2005 DD3PCA3 RNA Analysis in Urine – A New Perspective for Detecting Prostate Cancer M. Tinzl, M. Marberger, S. Horvath, C. Chypre European Urology 2004;46:182–186 http://dx.doi.org/10.1016/S0302-2838(13)00883-X
2008 Morbidity and Clinical Outcome of NephronSparing Surgery in Relation to Tumour Size and Indication J.-J. Patard, A.J. Pantuck, M. Crepel, J.S. Lam, L. Bellec, B. Albouy, D. Lopes, J.-C. Bernhard, F. Guillé, B. Lacroix, A. De La Taille, L. Salomon, C. Pfister, M. Soulié, J. Tostain, J.-M. Ferriere, C.C. Abbou, M. Colombel, A.S. Belldegrun European Urology 2007;52:148–154
2009 The Template of the Primary Lymphatic Landing Sites of the Prostate Should Be Revisited: Results of a Multimodality Mapping Study A. Mattei , F.G. Fuechsel, N. Bhatta Dhar, S.H. Warncke, G.N. Thalmann, T. Krause, U.E. Studer European Urology 2008;53:118–125
2010 Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) Classification of Renal Tumours in Patients who are Candidates for Nephron-Sparing Surgery V. Ficarra, G. Novara, S. Secco, V. Macchi, A. Porzionato, R. De Caro, W. Artibani European Urology 2009;56:786–793 Sponsored By Elsevier
2011 Positive Surgical Margin Appears to Have Negligible Impact on Survival of Renal Cell Carcinomas Treated by Nephron-Sparing Surgery K. Bensalah, A.J. Pantuck, N. Rioux-Leclercq, R. Thuret, F. Montorsi, P. Karakiewicz, N. Mottet, L. Zini, R. Bertini, L. Salomon, A. Villers, M. Soulie, L. Bellec, P. Rischmann, A. De La Taille, R. Avakian, M. Crepel, J. Ferriere, J. Bernhard, T. Dujardin, et al. European Urology 2010;57:466–473 Sponsored By Elsevier
The Platinum Hall of Fame 2012
2012
Pentafecta: A New Concept for Reporting Outcomes of Robot-Assisted Laparoscopic Radical Prostatectomy
Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Multi-institutional Collaboration
V. Patel, A. Sivaraman, R. Coelho, S. Chauhan, K. Palmer, M. Orvieto, I. Camacho, G. Coughlin, B. Rocco European Urology 2011;59:702–707
D. Chade, S. Shariat, A. Cronin, C. Savage, J. Karnes, M. Blute, A. Briganti, F. Montorsi, H. van der Poel, H. Van Poppel, S. Joniau, G. Godoy, A. Hurtado-Coll, M. Gleave, M. Dall’Oglio, M. Srougi, P. Scardino, J. Eastham European Urology 2011;60:205–210
2013 Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for MuscleInvasive Urothelial Bladder Cancer R. Rosenblatt, A. Sherif, E. Rintala, R. Wahlqvist, A. Ullén, S. Nilsson, P.-U. Malmström, the Nordic Urothelial Cancer Group European Urology 2012;61:1229–1238
Best Clinical Research Paper published from an author under 35
2007 Frozen Section for the Management of Intraoperatively Detected Palpable Tumor Lesions During Nerve-Sparing Scheduled Radical Prostatectomy C. Eichelberg, A. Erbersdobler, A. Haese, T. Schlomm, F.K.H. Chun, E. Currlin, J. Walz, T. Steuber, M. Graefen, H. Huland European Urology 2006;49:1011–1018
2008 Use of Haemostatic Agents and Glues during Laparoscopic Partial Nephrectomy: A Multi-Institutional Survey from the United States and Europe of 1347 Cases A. Breda, S.V. Stepanian, J.S. Lam, J.C. Liao, I.S. Gill, J.R. Colombo, G. Guazzoni, M.D. Stifelman, K.T. Perry, A. Celia, G. Breda, P. Fornara, S.V. Jackman, A. Rosales, J. Palou, M. Grasso, V. Pansadoro, V. Disanto, F. Porpiglia, C. Milani, C.C. Abbou, R. Gaston, G. Janetschek, N.A. Soomro, J.J. De la Rosette, P.M. Laguna, P.G. Schulam European Urology 2007;52:798–803
2009 Predictive Factors for Progression in Patients with Clinical Stage T1a Prostate Cancer in the PSA Era A. Descazeaud, M. Peyromaure, A. Salin, D. Amsellem-Ouazana, T. Flam, A. Viellefond, B. Debré, M. Zerbib European Urology 2008;53:355–362
2010 Should All Patients with Non–Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre Study S. Gudjónsson, L. Adell, F. Merdasa, R. Olsson, B. Larsson, T. Davidsson, J. Richthoff, G. Hagberg, M. Grabe, P.O. Bendahl, W. Månsson, F. Liedberg European Urology 2009;55:773–780 Sponsored By Eli Lilly
2011 Complications in 2200 Consecutive Laparoscopic Radical Prostatectomies: Standardized Evaluation and Analysis of Learning Curves M. Hruza, H. Weiß, G. Pini, A. Goezen, M. Schulze, D. Teber, J. Rassweiler European Urology 2010;58:733–741 Sponsored by Elsevier
2013 Stage-Specific Impact of Tumor Location on Oncologic Outcomes in Patients With Upper and Lower Tract Urothelial Carcinoma Following Radical Surgery M. Rink, B. Ehdaie, E.K. Cha, D.A. Green, P.I. Karakiewicz, M. Babjuk, V. Margulis, J.D. Raman, R.S. Svatek, H. Fajkovic, R.K. Lee, G. Novara, J. Hansen, S. Daneshmand, Y. Lotan, W. Kassouf, H.-M. Fritsche, A. Pycham, M. Fisch, D.S. Scherr, S.F. Shariat, for the Bladder Cancer Research Consortium (BCRC) and for the Upper Tract Urothelial Carcinoma Collaboration (UTUCC) European Urology 2012;62:677–684
Best Fundamental Research Paper published from an author under 35
2007 Depressed Contractile Responses to Neurokinin A in Idiopathic but not Neurogenic Overactive Human Detrusor Muscle D.J. Sellers, C.R. Chapple, D.P.W. Hay, R. Chess-Williams European Urology 2006;49:510–518
2008 Effects of the M3 Receptor Selective Muscarinic Antagonist Darifenacin on Bladder Afferent Activity of the Rat Pelvic Nerve K. Iijima, S. De Wachter, J.-J. Wyndaele European Urology 2007;52:842–849
2009 Marked Gene Transcript Level Alterations Occur Early During Radical Prostatectomy T. Schlomm, E. Näkel, A. Lübke, A. Buness, F.K.-H. Chun, T. Steuber, M. Graefen, R. Simon, G. Sauter, A. Poustka, H. Huland, A. Erbersdobler, H. Sültmann, O.J.C. Hellwinkel European Urology 2008;53:333–346
2010 Characteristics of Spontaneous Activity in the Bladder Trigone A. Roosen, C. Wu, G. Sui, R.A. Chowdhury, P.M. Patel, C.H. Fry European Urology 2009;56:346–354 Sponsored By Elsevier
2011 Stem Cell Characteristics in Prostate Cancer Cell Lines M.J. Pfeiffer, J.A. Schalken European Urology 2010;57:246–255 Sponsored By Elsevier
The Platinum Hall of Fame 2012 Transplantation of Autologous Differentiated Urothelium in an Experimental Model of Composite Cystoplasty A. Turner, R. Subramanian, D. Thomas, J. Hinley, S. Abbas, J. Stahlschmidt, J. Southgate European Urology 2011;59:447–454
2013 Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic Markers R. Kandimalla, A.A.G. van Tilborg, L.C. Kompier, D.J.P.M. Stumpel, R.W. Stam, C.H. Bangma, E.C. Zwarthoff European Urology 2012;61:1245–1256
Residents’ Corner
2008 Initial Biopsy Outcome Prediction—Head-to-Head Comparison of a Logistic Regression-Based Nomogram versus Artificial Neural Network F.K.-H. Chun, M. Graefen, A. Briganti, A. Gallina, J. Hopp, M.W. Kattan, H. Huland, P.I. Karakiewicz European Urology 2007;51:1236–1243
& hK2 and Free PSA, a Prognostic Combination in Predicting Minimal Prostate Cancer in Screen-Detected Men within the PSA Range 4–10 ng/ml R. Raaijmakers, S.H. de Vries, B.G. Blijenberg, M.F. Wildhagen, R. Postma, C.H. Bangma, C. Darte, F.H. Schröder European Urology 2007;52:1358–1364
2009 Evaluation of Prostate Cancer Detection with Ultrasound Real-Time Elastography: A Comparison with Step Section Pathological Analysis after Radical Prostatectomy G. Salomon, J. Köllerman, I. Thederan, F.K.H. Chun, L. Budäus, T. Schlomm, H. Isbarn, H. Heinzer, H. Huland, M. Graefen European Urology 2008;54:1354–1362
& Radical Prostatectomy for Incidental (Stage T1a–T1b) Prostate Cancer: Analysis of Predictors for Residual Disease and Biochemical Recurrence U. Capitanio, V. Scattoni, M. Freschi, A. Briganti, A. Salonia, A. Gallina, R. Colombo, P.I. Karakiewicz, P. Rigatti, F. Montorsi European Urology 2008;54:118–125
2010 Influence of Nerve Transsections and Combined Bladder Filling on Intravesical ElectrostimulationInduced Bladder Contraction in the Rat F. De Bock, S. De Wachter, J.J. Wyndaele European Urology 2009;56:527–533 Sponsored By Eli Lilly
& The Role of Biopsy Core Number in Selecting Prostate Cancer Patients for Active Surveillance G. Ploussard, E. Xylinas, L. Salomon, Y. Allory, D. Vordos, A. Hoznek, C.-C. Abbou, A. de la Taille European Urology 2009;56:891–898 Sponsored By Eli Lilly
2011 Midterm Prospective Evaluation of TVT-Secur Reveals High Failure Rate J.N. Cornu, P. Sèbe, L. Peyrat, C. Ciofu, O. Cussenot, F. Haab European Urology 2010;58:157–161
& HYAL-1 Hyaluronidase: A Potential Prognostic Indicator for Progression to Muscle Invasion and Recurrence in Bladder Cancer M.W. Kramer, R. Golshani, A.S. Merseburger, J. Knapp, A. Garcia, J. Hennenlotter, R.C. Duncan, M.S. Soloway, M. Jorda, M.A. Kuczyk, A. Stenzl, V.B. Lokeshwar European Urology 2010;57:86–94
2012 Exosomes as Biomarker Treasure Chests for Prostate Cancer D. Duijvesz, T. Luider, C. Bangma, G. Jenster European Urology 2011;59:823–831
& Cancer-Specific and Other-Cause Mortality After Radical Prostatectomy Versus Observation in Patients with Prostate Cancer: Competing-Risks Analysis of a Large North American Population-Based Cohort F. Abdollah, M. Sun, J. Schmitges, Z. Tian, C. Jeldres, A. Briganti, S. Shariat, P. Perrotte, F. Montorsi, P. Karakiewicz European Urology 2011;60:920–930
2013 Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort T. Hambrock, C. Hoeks, C. Hulsbergen-van de Kaa, T. Scheenen, J. Fütterer, S. Bouwense, I. van Oort, F. Schröder, H. Huisman, J. Barentsz European Urology 2012;61:177–184
& Immunocytology Is a Strong Predictor of Bladder Cancer Presence in Patients With Painless Hematuria: A Multicentre Study E.K. Cha, L.-A. Tirsar, C. Schwentner, P.J. Christos, C. Mian, J. Hennenlotter, T. Martini, A. Stenzl, A. Pycha, S.F. Shariat, B.J. Schmitz-Dräger European Urology 2012;61:185–192
The Platinum Hall of Fame Platinum Award Winners 2009 1. Fritz Schröder 2. Urs Studer Platinum Award Winners 2010 1. Christopher Chapple 2. Oliver Hakenberg 3. Rodolfo Montironi Platinum Award Winners 2011 1. Guido Dalbagni 2. Monique J. Roobol Platinum Award Winners 2012 1. Anders Bjartell 2. Markus Graefen 3. Mani Menon 4. Christian Stief 5. Tullio Sulser 6. Alexandre Zlotta Platinum Award Winners 2013 1. Per-Anders Abrahamsson 2. Walter Artibani 3. Jacqueline Roelofswaard 4. Maurice Schlief 5. Claude Schulman 6. Pierre Teillac 7. Manfred Wirth 8. Hendrik van Poppel 2007 Reviewers of the Month January: Massimo Maffezzini (Italy) February: Hiten R. H. Patel (UK) March: Pierre Karakiewicz (Canada) April: Christian Gratzke (Germany) May: Fred Witjes (The Netherlands) June: Ziya Kirkali (Turkey) July: Bertrand Guillonneau (USA) August: Chris Chapple (UK) September: Axel Heidenreich (Germany) October: Jean-Jacques Patard (France) November: Oliver Reich (Germany) Reviewer of the Year 2007 Vincenzo Ficarra (Italy)
2008 Reviewers of the Month January: Shahrokh Shariat (USA) February: Alberto Briganti (Italy) March: Alexander Bachmann (Switzerland) April: Scott Eggener (USA) May: Roger Dmochowski (USA) June: Felix K.-H. Chun (Germany) July: Giacomo Novara (Italy) August: Michael Blute (USA) September: Patrick Bastian (Germany) October: Rafael Badalyan (Armenia) November: Henk van der Poel (The Netherlands) Reviewer of the Year 2008 Pierre Karakiewicz (Canada) 2009 Reviewers of the Month January: Matthew Gettman (USA) February: Oliver Hakenberg (Germany) March: Riccardo Autorino (Italy) April: Urs Studer (Switzerland) May: Fritz Schröder (The Netherlands) June: Petrisor Geavlete (Romania) July: Clare Fowler (UK) August: Francisco Cruz (Portugal) September: John Denstedt (Canada) October: Jacques Irani (France) November: Apostolos Apostolidis (Greece) Reviewer of the Year 2009 Henk van der Poel (The Netherlands) 2010 Reviewers of the Month January: Ricarda Bauer (Germany) February: Declan Murphy (Australia) March: Harry Herr (USA) April: Marko Babjuk (Czech Republic) May: Umberto Capitanio (Italy) June: Stephen Freedland (USA) July: Richard Sylvester (Belgium) August: Rufus Cartwright (UK) September: Jens Rassweiler (Germany) October: Mike Kattan (USA) November: George Thalmann (Switzerland) Reviewers of the Year 2010 Michael Kattan (USA) Matthew Gettman (USA) Giacomo Novara (Italy)
The Platinum Hall of Fame 2011 Reviewers of the Month January: Ofer Yossepowitch (Israel) February: Theo de Reijke (The Netherlands) March: Evangelos Liatsikos (Greece) April: Christopher Eden (UK) May: Ofer Gofrit (Israel) June: James Catto (UK) July: R. Houston Thompson (USA) August: Karim Bensalah (France) September: Gianluca Giannarini (Italy) October: Mesut Remzi (Austria) November: Peter Albertsen (USA) Reviewer of the Year 2011 Alexander Bachmann (Switzerland) 2012 Reviewers of the Month January: Francesco Greco (Germany) February: Stephen Boorjian (USA) March: Jean-Nicolas Cornu (France) April: Mark Emberton (UK) May: Firas Abdollah (Italy) June: Stephan Madersbacher (Austria)
July: Michael Rink (Germany) August: Rik Bryan (UK) September: Sabine Brookman-May (Germany) October: Nicolas Mottet (France) November: Hendrik Isbarn (Germany) Reviewers of the Year 2012 Peter Albertsen (USA) Jean-Nicolas Cornu (France) Gianluca Giannarini (Switzerland) 2013 Reviewers of the Month January: Massimo Lazzeri (Italy) February: Guillaume Ploussard (France) March: Derya Tilki (Germany) April: Giuseppe Simone (Italy) May: Evanguelos Xylinas (USA) June: Joseph Chin (Canada) July: Rodolfo Montironi (Italy) August: Matthew Galsky (USA) September: Hashim Ahmed (UK) October: Peter Black (Canada) November: Tobias Klatte (Germany)
2006
2000
Prevalence of Asymptomatic Coronary Artery Disease in Men with Vasculogenic Erectile Dysfunction: A Prospective Angiographic Study
Laparoscopic Radical Prostatectomy: Technical and Early Oncological Assessment of 40 Operations B. Guillonneau, X. Cathelineau, E. Barret, F. Rozet, G. Vallancien European Urology 1999;36:14–20
2001 RPLND or Primary Chemotherapy in Clinical Stage IIA/B Nonseminomatous Germ Cell Tumors? Results of a Prospective Multicenter Trial Including Quality of Life Assessment
C. Vlachopoulos, K. Rokkas, N. Ioakeimidis, C. Aggeli, A. Michaelides, G. Roussakis, C. Fassoulakis, A. Askitis, C. Stefanadis European Urology 2005;48:996–1002
2007 Excellent Long-Term Cancer Control with Elective Nephron-Sparing Surgery for Selected Renal Cell Carcinomas Measuring More Than 4 cm F. Becker, S. Siemer, M. Hack, U. Humke, M. Ziegler, M. Stöckle European Urology 2006;49:1058–1064
L. Weissbach, R. Bussar-Maatz, H. Flechtner, U. Pichlmeier, M. Hartmann, L. Keller European Urology 2000;37:582–594
& Elective Nephron-Sparing Surgery Should Become Standard Treatment for Small Unilateral Renal Cell Carcinoma: Long-term Survival Data of 216 Patients
2002
F. Becker, S. Siemer, U. Humke, M. Hack, M. Ziegler, M. Stöckle European Urology 2006;49:308–313
Nonrandomized Comparison of Open Flank versus Laparoscopic Nephrectomy in 249 Patients with Benign Renal Disease P. Fornara, C. Doehn, H.-J. Friedrich, D. Jocham European Urology 2001;40:24–31
2003 Laparoscopic Dismembered Pyeloplasty – The Method of Choice in the Presence of an Enlarged Renal Pelvis and Crossing Vessels I.A. Türk, J.W. Davis, B. Winkelmann, S. Deger, F. Richter, M.D. Fabrizio, B. Schönberger, G.H. Jordan, S.A. Loening European Urology 2002;42:268–275
2004 The Side Effects of Bacillus Calmette-Guérin in the Treatment of Ta T1 Bladder Cancer do not Predict its Efficacy: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial R.J. Sylvester, A.P.M. Van Der Meijden, W. Oosterlinck, W. Hoeltl, A.V. Bono European Urology 2003;44:423–428
& Maintenance Bacillus Calmette-Guérin for Ta T1 Bladder Tumors is not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial A.P.M. Van Der Meijden, R.J. Sylvester, W. Oosterlinck, W. Hoeltl, A.V. Bono European Urology 2003;44:429–434
2005 DD3PCA3 RNA Analysis in Urine – A New Perspective for Detecting Prostate Cancer M. Tinzl, M. Marberger, S. Horvath, C. Chypre European Urology 2004;46:182–186 http://dx.doi.org/10.1016/S0302-2838(13)00883-X
2008 Morbidity and Clinical Outcome of NephronSparing Surgery in Relation to Tumour Size and Indication J.-J. Patard, A.J. Pantuck, M. Crepel, J.S. Lam, L. Bellec, B. Albouy, D. Lopes, J.-C. Bernhard, F. Guillé, B. Lacroix, A. De La Taille, L. Salomon, C. Pfister, M. Soulié, J. Tostain, J.-M. Ferriere, C.C. Abbou, M. Colombel, A.S. Belldegrun European Urology 2007;52:148–154
2009 The Template of the Primary Lymphatic Landing Sites of the Prostate Should Be Revisited: Results of a Multimodality Mapping Study A. Mattei , F.G. Fuechsel, N. Bhatta Dhar, S.H. Warncke, G.N. Thalmann, T. Krause, U.E. Studer European Urology 2008;53:118–125
2010 Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) Classification of Renal Tumours in Patients who are Candidates for Nephron-Sparing Surgery V. Ficarra, G. Novara, S. Secco, V. Macchi, A. Porzionato, R. De Caro, W. Artibani European Urology 2009;56:786–793 Sponsored By Elsevier
2011 Positive Surgical Margin Appears to Have Negligible Impact on Survival of Renal Cell Carcinomas Treated by Nephron-Sparing Surgery K. Bensalah, A.J. Pantuck, N. Rioux-Leclercq, R. Thuret, F. Montorsi, P. Karakiewicz, N. Mottet, L. Zini, R. Bertini, L. Salomon, A. Villers, M. Soulie, L. Bellec, P. Rischmann, A. De La Taille, R. Avakian, M. Crepel, J. Ferriere, J. Bernhard, T. Dujardin, et al. European Urology 2010;57:466–473 Sponsored By Elsevier
The Platinum Hall of Fame 2012
2012
Pentafecta: A New Concept for Reporting Outcomes of Robot-Assisted Laparoscopic Radical Prostatectomy
Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Multi-institutional Collaboration
V. Patel, A. Sivaraman, R. Coelho, S. Chauhan, K. Palmer, M. Orvieto, I. Camacho, G. Coughlin, B. Rocco European Urology 2011;59:702–707
D. Chade, S. Shariat, A. Cronin, C. Savage, J. Karnes, M. Blute, A. Briganti, F. Montorsi, H. van der Poel, H. Van Poppel, S. Joniau, G. Godoy, A. Hurtado-Coll, M. Gleave, M. Dall’Oglio, M. Srougi, P. Scardino, J. Eastham European Urology 2011;60:205–210
2013 Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for MuscleInvasive Urothelial Bladder Cancer R. Rosenblatt, A. Sherif, E. Rintala, R. Wahlqvist, A. Ullén, S. Nilsson, P.-U. Malmström, the Nordic Urothelial Cancer Group European Urology 2012;61:1229–1238
Best Clinical Research Paper published from an author under 35
2007 Frozen Section for the Management of Intraoperatively Detected Palpable Tumor Lesions During Nerve-Sparing Scheduled Radical Prostatectomy C. Eichelberg, A. Erbersdobler, A. Haese, T. Schlomm, F.K.H. Chun, E. Currlin, J. Walz, T. Steuber, M. Graefen, H. Huland European Urology 2006;49:1011–1018
2008 Use of Haemostatic Agents and Glues during Laparoscopic Partial Nephrectomy: A Multi-Institutional Survey from the United States and Europe of 1347 Cases A. Breda, S.V. Stepanian, J.S. Lam, J.C. Liao, I.S. Gill, J.R. Colombo, G. Guazzoni, M.D. Stifelman, K.T. Perry, A. Celia, G. Breda, P. Fornara, S.V. Jackman, A. Rosales, J. Palou, M. Grasso, V. Pansadoro, V. Disanto, F. Porpiglia, C. Milani, C.C. Abbou, R. Gaston, G. Janetschek, N.A. Soomro, J.J. De la Rosette, P.M. Laguna, P.G. Schulam European Urology 2007;52:798–803
2009 Predictive Factors for Progression in Patients with Clinical Stage T1a Prostate Cancer in the PSA Era A. Descazeaud, M. Peyromaure, A. Salin, D. Amsellem-Ouazana, T. Flam, A. Viellefond, B. Debré, M. Zerbib European Urology 2008;53:355–362
2010 Should All Patients with Non–Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre Study S. Gudjónsson, L. Adell, F. Merdasa, R. Olsson, B. Larsson, T. Davidsson, J. Richthoff, G. Hagberg, M. Grabe, P.O. Bendahl, W. Månsson, F. Liedberg European Urology 2009;55:773–780 Sponsored By Eli Lilly
2011 Complications in 2200 Consecutive Laparoscopic Radical Prostatectomies: Standardized Evaluation and Analysis of Learning Curves M. Hruza, H. Weiß, G. Pini, A. Goezen, M. Schulze, D. Teber, J. Rassweiler European Urology 2010;58:733–741 Sponsored by Elsevier
2013 Stage-Specific Impact of Tumor Location on Oncologic Outcomes in Patients With Upper and Lower Tract Urothelial Carcinoma Following Radical Surgery M. Rink, B. Ehdaie, E.K. Cha, D.A. Green, P.I. Karakiewicz, M. Babjuk, V. Margulis, J.D. Raman, R.S. Svatek, H. Fajkovic, R.K. Lee, G. Novara, J. Hansen, S. Daneshmand, Y. Lotan, W. Kassouf, H.-M. Fritsche, A. Pycham, M. Fisch, D.S. Scherr, S.F. Shariat, for the Bladder Cancer Research Consortium (BCRC) and for the Upper Tract Urothelial Carcinoma Collaboration (UTUCC) European Urology 2012;62:677–684
Best Fundamental Research Paper published from an author under 35
2007 Depressed Contractile Responses to Neurokinin A in Idiopathic but not Neurogenic Overactive Human Detrusor Muscle D.J. Sellers, C.R. Chapple, D.P.W. Hay, R. Chess-Williams European Urology 2006;49:510–518
2008 Effects of the M3 Receptor Selective Muscarinic Antagonist Darifenacin on Bladder Afferent Activity of the Rat Pelvic Nerve K. Iijima, S. De Wachter, J.-J. Wyndaele European Urology 2007;52:842–849
2009 Marked Gene Transcript Level Alterations Occur Early During Radical Prostatectomy T. Schlomm, E. Näkel, A. Lübke, A. Buness, F.K.-H. Chun, T. Steuber, M. Graefen, R. Simon, G. Sauter, A. Poustka, H. Huland, A. Erbersdobler, H. Sültmann, O.J.C. Hellwinkel European Urology 2008;53:333–346
2010 Characteristics of Spontaneous Activity in the Bladder Trigone A. Roosen, C. Wu, G. Sui, R.A. Chowdhury, P.M. Patel, C.H. Fry European Urology 2009;56:346–354 Sponsored By Elsevier
2011 Stem Cell Characteristics in Prostate Cancer Cell Lines M.J. Pfeiffer, J.A. Schalken European Urology 2010;57:246–255 Sponsored By Elsevier
The Platinum Hall of Fame 2012 Transplantation of Autologous Differentiated Urothelium in an Experimental Model of Composite Cystoplasty A. Turner, R. Subramanian, D. Thomas, J. Hinley, S. Abbas, J. Stahlschmidt, J. Southgate European Urology 2011;59:447–454
2013 Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic Markers R. Kandimalla, A.A.G. van Tilborg, L.C. Kompier, D.J.P.M. Stumpel, R.W. Stam, C.H. Bangma, E.C. Zwarthoff European Urology 2012;61:1245–1256
Residents’ Corner
2008 Initial Biopsy Outcome Prediction—Head-to-Head Comparison of a Logistic Regression-Based Nomogram versus Artificial Neural Network F.K.-H. Chun, M. Graefen, A. Briganti, A. Gallina, J. Hopp, M.W. Kattan, H. Huland, P.I. Karakiewicz European Urology 2007;51:1236–1243
& hK2 and Free PSA, a Prognostic Combination in Predicting Minimal Prostate Cancer in Screen-Detected Men within the PSA Range 4–10 ng/ml R. Raaijmakers, S.H. de Vries, B.G. Blijenberg, M.F. Wildhagen, R. Postma, C.H. Bangma, C. Darte, F.H. Schröder European Urology 2007;52:1358–1364
2009 Evaluation of Prostate Cancer Detection with Ultrasound Real-Time Elastography: A Comparison with Step Section Pathological Analysis after Radical Prostatectomy G. Salomon, J. Köllerman, I. Thederan, F.K.H. Chun, L. Budäus, T. Schlomm, H. Isbarn, H. Heinzer, H. Huland, M. Graefen European Urology 2008;54:1354–1362
& Radical Prostatectomy for Incidental (Stage T1a–T1b) Prostate Cancer: Analysis of Predictors for Residual Disease and Biochemical Recurrence U. Capitanio, V. Scattoni, M. Freschi, A. Briganti, A. Salonia, A. Gallina, R. Colombo, P.I. Karakiewicz, P. Rigatti, F. Montorsi European Urology 2008;54:118–125
2010 Influence of Nerve Transsections and Combined Bladder Filling on Intravesical ElectrostimulationInduced Bladder Contraction in the Rat F. De Bock, S. De Wachter, J.J. Wyndaele European Urology 2009;56:527–533 Sponsored By Eli Lilly
& The Role of Biopsy Core Number in Selecting Prostate Cancer Patients for Active Surveillance G. Ploussard, E. Xylinas, L. Salomon, Y. Allory, D. Vordos, A. Hoznek, C.-C. Abbou, A. de la Taille European Urology 2009;56:891–898 Sponsored By Eli Lilly
2011 Midterm Prospective Evaluation of TVT-Secur Reveals High Failure Rate J.N. Cornu, P. Sèbe, L. Peyrat, C. Ciofu, O. Cussenot, F. Haab European Urology 2010;58:157–161
& HYAL-1 Hyaluronidase: A Potential Prognostic Indicator for Progression to Muscle Invasion and Recurrence in Bladder Cancer M.W. Kramer, R. Golshani, A.S. Merseburger, J. Knapp, A. Garcia, J. Hennenlotter, R.C. Duncan, M.S. Soloway, M. Jorda, M.A. Kuczyk, A. Stenzl, V.B. Lokeshwar European Urology 2010;57:86–94
2012 Exosomes as Biomarker Treasure Chests for Prostate Cancer D. Duijvesz, T. Luider, C. Bangma, G. Jenster European Urology 2011;59:823–831
& Cancer-Specific and Other-Cause Mortality After Radical Prostatectomy Versus Observation in Patients with Prostate Cancer: Competing-Risks Analysis of a Large North American Population-Based Cohort F. Abdollah, M. Sun, J. Schmitges, Z. Tian, C. Jeldres, A. Briganti, S. Shariat, P. Perrotte, F. Montorsi, P. Karakiewicz European Urology 2011;60:920–930
2013 Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort T. Hambrock, C. Hoeks, C. Hulsbergen-van de Kaa, T. Scheenen, J. Fütterer, S. Bouwense, I. van Oort, F. Schröder, H. Huisman, J. Barentsz European Urology 2012;61:177–184
& Immunocytology Is a Strong Predictor of Bladder Cancer Presence in Patients With Painless Hematuria: A Multicentre Study E.K. Cha, L.-A. Tirsar, C. Schwentner, P.J. Christos, C. Mian, J. Hennenlotter, T. Martini, A. Stenzl, A. Pycha, S.F. Shariat, B.J. Schmitz-Dräger European Urology 2012;61:185–192
The Platinum Hall of Fame Platinum Award Winners 2009 1. Fritz Schröder 2. Urs Studer Platinum Award Winners 2010 1. Christopher Chapple 2. Oliver Hakenberg 3. Rodolfo Montironi Platinum Award Winners 2011 1. Guido Dalbagni 2. Monique J. Roobol Platinum Award Winners 2012 1. Anders Bjartell 2. Markus Graefen 3. Mani Menon 4. Christian Stief 5. Tullio Sulser 6. Alexandre Zlotta Platinum Award Winners 2013 1. Per-Anders Abrahamsson 2. Walter Artibani 3. Jacqueline Roelofswaard 4. Maurice Schlief 5. Claude Schulman 6. Pierre Teillac 7. Manfred Wirth 8. Hendrik van Poppel 2007 Reviewers of the Month January: Massimo Maffezzini (Italy) February: Hiten R. H. Patel (UK) March: Pierre Karakiewicz (Canada) April: Christian Gratzke (Germany) May: Fred Witjes (The Netherlands) June: Ziya Kirkali (Turkey) July: Bertrand Guillonneau (USA) August: Chris Chapple (UK) September: Axel Heidenreich (Germany) October: Jean-Jacques Patard (France) November: Oliver Reich (Germany) Reviewer of the Year 2007 Vincenzo Ficarra (Italy)
2008 Reviewers of the Month January: Shahrokh Shariat (USA) February: Alberto Briganti (Italy) March: Alexander Bachmann (Switzerland) April: Scott Eggener (USA) May: Roger Dmochowski (USA) June: Felix K.-H. Chun (Germany) July: Giacomo Novara (Italy) August: Michael Blute (USA) September: Patrick Bastian (Germany) October: Rafael Badalyan (Armenia) November: Henk van der Poel (The Netherlands) Reviewer of the Year 2008 Pierre Karakiewicz (Canada) 2009 Reviewers of the Month January: Matthew Gettman (USA) February: Oliver Hakenberg (Germany) March: Riccardo Autorino (Italy) April: Urs Studer (Switzerland) May: Fritz Schröder (The Netherlands) June: Petrisor Geavlete (Romania) July: Clare Fowler (UK) August: Francisco Cruz (Portugal) September: John Denstedt (Canada) October: Jacques Irani (France) November: Apostolos Apostolidis (Greece) Reviewer of the Year 2009 Henk van der Poel (The Netherlands) 2010 Reviewers of the Month January: Ricarda Bauer (Germany) February: Declan Murphy (Australia) March: Harry Herr (USA) April: Marko Babjuk (Czech Republic) May: Umberto Capitanio (Italy) June: Stephen Freedland (USA) July: Richard Sylvester (Belgium) August: Rufus Cartwright (UK) September: Jens Rassweiler (Germany) October: Mike Kattan (USA) November: George Thalmann (Switzerland) Reviewers of the Year 2010 Michael Kattan (USA) Matthew Gettman (USA) Giacomo Novara (Italy)
The Platinum Hall of Fame 2011 Reviewers of the Month January: Ofer Yossepowitch (Israel) February: Theo de Reijke (The Netherlands) March: Evangelos Liatsikos (Greece) April: Christopher Eden (UK) May: Ofer Gofrit (Israel) June: James Catto (UK) July: R. Houston Thompson (USA) August: Karim Bensalah (France) September: Gianluca Giannarini (Italy) October: Mesut Remzi (Austria) November: Peter Albertsen (USA) Reviewer of the Year 2011 Alexander Bachmann (Switzerland) 2012 Reviewers of the Month January: Francesco Greco (Germany) February: Stephen Boorjian (USA) March: Jean-Nicolas Cornu (France) April: Mark Emberton (UK) May: Firas Abdollah (Italy) June: Stephan Madersbacher (Austria)
July: Michael Rink (Germany) August: Rik Bryan (UK) September: Sabine Brookman-May (Germany) October: Nicolas Mottet (France) November: Hendrik Isbarn (Germany) Reviewers of the Year 2012 Peter Albertsen (USA) Jean-Nicolas Cornu (France) Gianluca Giannarini (Switzerland) 2013 Reviewers of the Month January: Massimo Lazzeri (Italy) February: Guillaume Ploussard (France) March: Derya Tilki (Germany) April: Giuseppe Simone (Italy) May: Evanguelos Xylinas (USA) June: Joseph Chin (Canada) July: Rodolfo Montironi (Italy) August: Matthew Galsky (USA) September: Hashim Ahmed (UK) October: Peter Black (Canada) November: Tobias Klatte (Germany)